Drug Discovery
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
cGMP Manufacture | Drug Development | Drug Discovery | Formulation Development | Industry News | Methods Development
Avista Pharma Details One-Stop-Shop Offerings
Analytical services director, Katie Schlipp, spoke with Contract Pharma at BIO 2018Videos
-
Bio News | cGMP Manufacture | Drug Development | Drug Discovery | Facilities | Industry News
-
Bioanalytical Services | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Information Technology
Comprehend Systems Joins Veeva Partner Program
To integrate solutions with Veeva Vault EDC & CTMS to provide pharma companies real-time performance & risk monitoring06.21.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Syneos, Elligo Enter Strategic Collaboration
To build a central infrastructure & research system around physicians & patients who aren't accessible in traditional sites06.21.18
-
APIs | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Discovery | Industry News
Enamine and TBD Biodiscovery Collaborate to Provide GMP-based Services
Collaboration combines expertise in novel chemical compound synthesis with GMP manufacture in drug discovery06.20.18
-
Collaborations & Alliances | Drug Discovery
CrownBio, Pierre Fabre In Immuno-Oncology Alliance
CrownBio to engraft PDX models selected by Pierre Fabre into CD34+ humanized mouse models06.19.18
-
Drug Development | Drug Discovery | Industry News | R&D
BridgeBio Launches CoA Therapeutics
To develop novel small-molecules designed to increase CoA levels in genetic disorders where CoA deficiency is implicated06.14.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Artelo, Syngene Enter Partnership
For the drug discovery and clinical development of ART27.13, Artelo's Phase 2 ready, high-potency dual cannabinoid agonist06.14.18
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
LakePharma, Harbour Antibodies Form Discovery Partnership
Agreement provides access to H2L2 platform use with LakePharma's discovery and develop-ment services06.14.18
-
Drug Development | Drug Discovery | Facilities | Industry News
Eisai Launches Dementia Discovery Center
Over $100 million committed as an initial investment to establish the new 50,000 sq. ft. discovery center in Cambridge, MA06.14.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Alcami Extends Workbench Laboratory Services Program
To support the ongoing manufacturing and development of ZILRETTA for Flexion Therapeutics06.13.18
-
Bioassay Development | Breaking News | Drug Discovery | Facilities
Thermo Fisher Opens U.S. Precision Medicine Science Center
Supports development of analytical workflows to generate precise molecular profiles of patients06.12.18
-
Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Microbiotica, Genentech Announce Collaboration
To discover, develop and commercialize biomarkers, targets and medicines for inflammatory bowel disease06.12.18
-
Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Alexion, Complement Enter Partnership
To co-develop the preclinical C6 complement inhibitor CP010 for neurodegenerative disorders06.12.18
-
Drug Discovery | Industry News | Information Technology
WuXi AppTec Invests in Insilico Medicine
Aims to accelerate drug discovery using next-gen artificial intelligence06.11.18
-
Bio News | Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery
GE, XPH Enter FlexFactory Agreement
To scale up, digitize & accelerate manufacturing processes for their cell therapy clinical trials & future commercialization06.07.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Lonza & Innosieve Enter Distribution Agreement
Lonza to sell, distribute Innosieve Diagnostics’ MuScan™ Instrument, Sieve-ID® Total Viable Count Kit and associated software06.04.18
-
Bio News | Drug Development | Drug Discovery | Facilities | Industry News
Maximizing Discovery & Innovation While Minimizing Cost
Amrit Chaudhuri, founder & CEO of Mass Innovation Labs, shares insight on the company's inspiration & missionOnline Exclusives Betsy Louda, Associate Editor 05.31.18
-
Bio News | Clinical Trials | Drug Discovery | Industry News | Trials & Filings
FDA Grants Curis Fast Track Designation
For fimepinostat (formerly CUDC-907) in adult patients with relapsed or refractory diffuse large B-cell lymphoma05.31.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News
Catalent, InterveXion Announce First Enrollment in STAMPOUT
The first trial in methamphetamine users of the first-in-class anti-methamphetamine antibody IXT-m20005.31.18
